Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 671 shares at $51.98 ($35K) on 2020-03-09, disclosed to the SEC on 2020-03-11.
Seasonal sale ($35k) by Chief Operating Officer — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |